0
     

Report Added
Report already added
Asia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific onychomycosis treatment market will grow by 9.3% annually with a total addressable market cap of $10,998.9 million over 2022-2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure.
Highlighted with 28 tables and 39 figures, this 93-page report “Asia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific onychomycosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Country.

Based on Onychomycosis Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Distal Subungual Onychomycosis
•White Superficial Onychomycosis
•Proximal Subungual Onychomycosis
•Candidal Onychomycosis
•Other Onychomycosis Types

Based on Treatment Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Drug Treatment
•Laser Therapy
•Photodynamic Therapy
•Other Therapies

By Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Hospitals and Clinics
•Online Stores
•Retail Pharmacies
•Other Distribution Channels

Geographically, the following national/local markets are fully investigated:
•Japan
•China
•South Korea
•Australia
•India
•Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction6
1.1 Industry Definition and Research Scope6
1.1.1 Industry Definition6
1.1.2 Research Scope7
1.2 Research Methodology10
1.2.1 Overview of Market Research Methodology10
1.2.2 Market Assumption11
1.2.3 Secondary Data11
1.2.4 Primary Data11
1.2.5 Data Filtration and Model Design12
1.2.6 Market Size/Share Estimation13
1.2.7 Research Limitations14
1.3 Executive Summary15
2 Market Overview and Dynamics17
2.1 Market Size and Forecast17
2.1.1 Impact of COVID-19 on World Economy18
2.1.2 Impact of COVID-19 on the Market20
2.2 Major Growth Drivers22
2.3 Market Restraints and Challenges29
2.4 Emerging Opportunities and Market Trends32
2.5 Porter’s Fiver Forces Analysis36
3 Segmentation of Asia Pacific Market by Onychomycosis Type40
3.1 Market Overview by Onychomycosis Type40
3.2 Distal Subungual Onychomycosis42
3.3 White Superficial Onychomycosis43
3.4 Proximal Subungual Onychomycosis44
3.5 Candidal Onychomycosis45
3.6 Other Onychomycosis Types46
4 Segmentation of Asia Pacific Market by Treatment Type47
4.1 Market Overview by Treatment Type47
4.2 Drug Treatment49
4.3 Laser Therapy50
4.4 Photodynamic Therapy51
4.5 Other Therapies52
5 Segmentation of Asia Pacific Market by Distribution Channel53
5.1 Market Overview by Distribution Channel53
5.2 Hospitals and Clinics55
5.3 Online Stores56
5.4 Retail Pharmacies57
5.5 Other Distribution Channels58
6 Asia-Pacific Market 2021-2031 by Country59
6.1 Overview of Asia-Pacific Market59
6.2 Japan62
6.3 China65
6.4 Australia67
6.5 India69
6.6 South Korea71
6.7 Rest of APAC Region73
7 Competitive Landscape75
7.1 Overview of Key Vendors75
7.2 New Product Launch, Partnership, Investment, and M&A78
7.3 Company Profiles79
Bausch Health Companies Inc.79
Bayer AG81
Cipla Ltd82
Dr. Reddys Laboratories Ltd83
Galderma SA84
GlaxoSmithKline PLC85
Johnson & Johnson86
Lumenis Ltd87
Medimetriks Pharmaceuticals Inc.88
Moberg Pharma AB89
Novartis AG90
Pfizer Inc.91
Sanofi SA92
RELATED REPORTS93

List of Tables:

Table 1. Snapshot of Asia Pacific Onychomycosis Treatment Market in Balanced Perspective, 2021-203116
Table 2. World Economic Outlook, 2021-203119
Table 3. Clinical Trials of Onychomycosis Treatment25
Table 4. World Health Spending by Region, $ bn, 2013-202028
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Onychomycosis Treatment Market32
Table 6. Asia Pacific Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn40
Table 7. Asia Pacific Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn47
Table 8. Asia Pacific Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn53
Table 9. APAC Onychomycosis Treatment Market by Country, 2021-2031, $ mn60
Table 10. Japan Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn64
Table 11. Japan Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn64
Table 12. Japan Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn64
Table 13. China Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn66
Table 14. China Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn66
Table 15. China Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn66
Table 16. Australia Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn68
Table 17. Australia Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn68
Table 18. Australia Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn68
Table 19. India Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn70
Table 20. India Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn70
Table 21. India Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn70
Table 22. South Korea Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn72
Table 23. South Korea Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn72
Table 24. South Korea Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn72
Table 25. Onychomycosis Treatment Market in Rest of APAC by Country/Region, 2021-2031, $ mn74
Table 26. Bausch Health Companies Inc.: Company Snapshot79
Table 27. Bausch Health Companies Inc.: Business Segmentation80
Table 28. Bausch Health Companies Inc.: Product Portfolio80

Report Title: Asia Pacific Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

China Bispecific Antibody Market Opportunity & Clinical Trials Insight 2028

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Vietnam Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Venezuela Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Uruguay Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 United Arab Emirates Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline

2022 Ukraine Clinical Chemistry and Immunodiagnostic Analyzers and Reagents for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Tests -- High-Growth Opportunities for Suppliers, Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts through 2026, Latest Technologies and Instrumentation Pipeline